CNO Financial Group, Inc.
NYSE:CNOInsurance - Life
+$0.03 today
- Market cap
- $5.14B
- Beta
- 0.84
- P/E (TTM)
- 19.6
- EPS (TTM)
- $2.61
- Dividend yield
- 1.35%
Volume 0.67M
Average 0.71M
CNO Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
CNO Financial Group, Inc.NYSE: CNO
Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026
Cost of revenue growth accelerates
Q2 FY2026 cost of revenue of $727.2M rose 3.4% year over year, ahead of the -2.8% change in trailing-twelve-month cost of revenue. Sequentially, it rose 27.6% from the prior quarter. Over 3 fiscal years it compounded at +11.5% a year.
Context
- Cost of revenue amounted to 55.2% of revenue in FY2025, down 6.5 pp from a year earlier.
- Cost of revenue increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +3.4% holds above the trailing-twelve-month pace of -2.8%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 2.48B USD
- Year-over-year change
- -9.7%
- 4-year CAGR
- +0.6%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.48B | -9.7% |
| FY2024 | 2024-12-31 | 2.74B | +4.9% |
| FY2023 | 2023-12-31 | 2.61B | +46.3% |
| FY2022 | 2022-12-31 | 1.79B | -26.3% |
| FY2021 | 2021-12-31 | 2.42B | — |
Cost of Revenue vs competitors
How CNO compares with its peers on the latest reported figures
- CNO's LTM Jun 2026 cost of revenue of $2.63B is the 3rd highest of the 9 companies compared; the peer median is $636.02M.
- Its year-over-year change of -2.8% is the 2nd highest of 9, against a peer median of -16.9%.
- Cost of revenue amounts to 56.6% of revenue for CNO, versus a peer median of 39.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $4.15B | -37.8% | -7.2% | 59.4% | |
| LTM Jun 2026 | $4.08B | +15.3% | +52.1% | 68.3% | |
| LTM Jun 2026 | $2.63B | -2.8% | +11.5% | 56.6% | |
| LTM Sep 2026 | $2.22B | -35.4% | +218.2% | 40.9% | |
| LTM Sep 2026 | $735.98M | -12.0% | +33.0% | 37.3% | |
| LTM Jun 2026 | $536.07M | -4.5% | +4.1% | 27.6% | |
| LTM Sep 2026 | $435.2M | -13.7% | +57.3% | 41.3% | |
| LTM Sep 2026 | $150.46M | -20.0% | +0.6% | 22.6% | |
| LTM Sep 2026 | $58M | -34.1% | +23.1% | 6.6% | |
| Peer median (excluding CNO) | $636.02M | -16.9% | +28.1% | 39.1% | |
Competitors are the stored peer set for CNO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 4.12B | 3.58B | 4.15B | 4.45B | 4.49B |
| Cost of Revenue | 2.42B | 1.79B | 2.61B | 2.74B | 2.48B |
| Gross Profit | 1.7B | 1.79B | 1.53B | 1.7B | 2.01B |
| Gross Margin | 41.2% | 50.1% | 37.0% | 38.3% | 44.8% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 267.9M | 287.9M | 290.9M | 304.5M | 0 |
| Operating Expenses | 966.3M | 973.7M | 1.18B | 1.18B | 1.72B |
| Depreciation & Amortization | 236.6M | 248.5M | 267.4M | 292.4M | 318.5M |
| EBITDA | 1.07B | 1.2B | 862.8M | 1.07B | 842.8M |
| EBITDA Margin | 25.8% | 33.6% | 20.8% | 24.0% | 18.8% |
| Operating Income | 733.1M | 816.5M | 356.8M | 518.3M | 293.4M |
| Operating Margin | 17.8% | 22.8% | 8.6% | 11.7% | 6.5% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 95.4M | 137M | 238.6M | 254.4M | 230.9M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 733.1M | 816.5M | 356.8M | 518.3M | 293.4M |
| Pre-Tax Margin | 17.8% | 22.8% | 8.6% | 11.7% | 6.5% |
| Income Tax Expense | 162.8M | 185.9M | 80.3M | 114.3M | 64.1M |
| Net Income | 570.3M | 630.6M | 276.5M | 404M | 229.3M |
| Net Margin | 13.8% | 17.6% | 6.7% | 9.1% | 5.1% |
| EPS (Basic) | 3.43 | 5.45 | 2.44 | 3.81 | 2.35 |
| EPS (Diluted) | 3.36 | 5.36 | 2.40 | 3.74 | 2.35 |
| Weighted Avg Shares | 128.4M | 117.65M | 113.28M | 106.14M | 97.76M |
| Weighted Avg Shares (Diluted) | 131.13M | 117.72M | 115.12M | 108.12M | 97.76M |
CNO Financial Group, Inc.
NYSE:CNO
Intrinsic Alpha fair value
Locked
Current Price
$56.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.